CoreAge Rx now has a public injectable TRT page linked from its treatment navigation and product sitemap. It names testosterone cypionate, advertises a starting price of $129 per month, and describes the medication as compounded in the United States. The main action currently reads “Coming soon,” so a published listing is not proof that enrollment is open.
We checked the page on September 27, 2026 and updated our earlier finding that a TRT-specific listing had not been verified. CoreAge remains this publication’s publisher-selected promotional first placement. The review describes public information; we have not purchased treatment, submitted a medical history, or tested clinical outcomes.
KEEP IN MIND
The useful bits.
- A TRT product URL and advertised $129 starting price are verified.
- The primary action still says Coming soon; current enrollment is not established.
- Confirm the full quote, pharmacy, lab plan, and conflicting general billing terms.
The treatment URL is now established
The relevant destination is CoreAge’s injectable TRT product page, linked in the sources below. Our promotional links now lead there with article-specific tracking parameters. That is a better destination for someone researching testosterone than the general homepage, where several unrelated treatment categories share space.
We confirmed that the visible primary control says Coming soon and did not identify a working TRT checkout link attached to it. Other page copy mentions ordering, but that does not establish current enrollment. Ask the company when this particular service opens and whether it will cover your state; do not assume that another product’s checkout is a TRT intake.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status
What the medication description establishes
The page identifies testosterone cypionate and displays a concentration of 200 mg/mL. Concentration is not an individual dose or a schedule. The prescribing clinician must decide whether treatment is appropriate and provide the exact prescription and administration instructions. The page’s general discussion of injection routes should not become a self-directed injection plan.
CoreAge labels the offering as compounded. FDA-approved testosterone cypionate products also exist, but evidence and approval for those finished products do not automatically transfer to this preparation. Compounded drugs are not FDA-approved. Ask for the dispensing pharmacy, formulation, and reason for using the proposed product; the public TRT page does not name your pharmacy.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status · FDA: understanding the risks of compounded drugs · Pfizer: Depo-Testosterone prescribing information
Read $129 as an advertised starting figure
The product page says as low as $129 per month, with no membership fee and free-delivery language. It does not provide a complete itemized personal quote identifying the starting laboratory charge, repeat labs, exact supply, and all professional-care charges. Those details remain open even though the advertised starting figure is now verified.
Before payment becomes available, request the total due, the amount of medication supplied, the renewal period, and which tests or visits are separate. Our CoreAge cost guide explains how to build that estimate. An advertised monthly equivalent does not tell you whether the first purchase will cover one month or a longer period.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status · CoreAge Rx: refund, subscription, and shipping policy
The laboratory description needs a local plan
The page describes blood work and clinician review before approval. One section mentions home phlebotomy or an in-person draw; its TRT FAQ names local Quest locations. Confirm the collection arrangement for your address, the panel ordered, any additional fee, and whether an existing report can be accepted.
A convenient draw is only one part of a diagnostic assessment. Symptoms, repeat appropriately timed testosterone measurements, medical history, and the cause of low levels matter. Use our testing guide to prepare. We did not verify CoreAge’s exact repeat-testing rules, outside-lab acceptance criteria, or individual follow-up schedule from the product page.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status · Endocrine Society: testosterone therapy clinical guidance
Resolve the billing and refund differences in writing
CoreAge’s general FAQ says there are no automatic rebills and describes a full refund if a provider does not approve treatment. Its separate refund policy allows subscription plans and says an applicable $50–$100 consultation fee can be nonrefundable after medical review. These statements need clarification for the actual TRT plan rather than being treated as a single consistent promise.
The policy also describes a 30-day refund cutoff and says an approved prescription transmitted for pharmacy fulfillment becomes final, even before shipment. These are the company’s published terms, not our conclusion about anyone’s legal rights. Obtain the applicable agreement and ask what happens if required records, lab work, or clinical eligibility delay the order.
Sources: CoreAge Rx: general service, billing, and pharmacy FAQ · CoreAge Rx: refund, subscription, and shipping policy
Confirm continuing care before committing
The TRT page promotes ongoing support, but a support promise does not establish the response time of a prescribing clinician. Ask who reviews follow-up results, how blood pressure and blood counts will be monitored, and how to report side effects. The monitoring checklist helps organize those responsibilities without choosing a treatment for you.
For a commercial comparison, read CoreAge versus TRT Nation. CoreAge now supplies meaningful product and price information; opening status, the full quote, individual eligibility, and dispensing details still need confirmation. Its first placement remains disclosed promotion, not a clinical score or evidence that it is the best fit for every reader.
Sources: CoreAge Rx: injectable TRT product page and Coming soon status · CoreAge Rx: general service, billing, and pharmacy FAQ · FDA: 2025 testosterone labeling and blood pressure changes
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Source review: September 27, 2026. Prices and availability can change.
- CoreAge Rx: injectable TRT product page and Coming soon status
- FDA: understanding the risks of compounded drugs
- Pfizer: Depo-Testosterone prescribing information
- CoreAge Rx: refund, subscription, and shipping policy
- Endocrine Society: testosterone therapy clinical guidance
- CoreAge Rx: general service, billing, and pharmacy FAQ
- FDA: 2025 testosterone labeling and blood pressure changes
A FREE TAKE-HOME FROM THE DESK
Before you commit,
put it on paper.
Get the TRT Decision Kit: a first-year cost worksheet, 12 questions to ask a clinic, and a checklist for reading the fine print.
Free for every subscriber. Educational resources, with five short daily emails to help you use them. No purchase needed.
See what’s in the kit ↗Form not loading? Open the signup form. Privacy & email preferences.
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.